The big solar panel installer has announced its second East Coast deal in a month: It’s buying the residential solar business of Vermont-based groSolar, after picking up Maryland’s Clean Currents. And SolarCity isn’t the only W…
French drug company Sanofi-Aventis (SNY) has finally made a deal to buy biotech company Genzyme (GENZ) for $20.1 billion, about $74 a share. Genzyme shareholders will get a contingent value right that represents potential future payments if Lemtrada, t…
What is preventing the French pharmaceutical group and U.S. biotech from reaching a merger agreement?
Continue reading Still No Deal Between Sanofi-Aventis and Genzyme
Still No Deal Between Sanof…
The fabled New York Stock Exchange isn’t what it used to be. Today’s NYSE Euronext has lost a huge volume of trading to upstart computerized exchanges in recent years, and scandals have tarnished its luster. Now, Germany’s Deut…
Nothing like a big media deal to spark commentary from the media. And indeed, there’s been no shortage of reaction — from praise to pillory — to AOL’s decision to purchase upstart news site The Huffington Post for $315 millio…